Cory Jubinville, PhD
Stock Analyst at LifeSci Capital
(4.57)
# 933
Out of 4,356 analysts
159
Total ratings
52%
Success rate
20.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cory Jubinville, PhD
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNYA Tenaya Therapeutics | Reiterated: Buy | $3 → $4 | $0.869 | +360.30% | 30 | May 15, 2026 | |
| PRME Prime Medicine | Rated: Buy | $6 | $3.55 | +69.01% | 4 | May 9, 2026 | |
| MREO Mereo BioPharma Group | Maintained: Hold | n/a | $0.344 | - | 14 | Jan 12, 2026 | |
| CRNX Crinetics Pharmaceuticals | Maintained: Buy | $93 → $99 | $35.55 | +178.48% | 30 | Jan 5, 2026 | |
| SION Sionna Therapeutics | Initiated Coverage: Buy | $60 | $42.82 | +40.12% | 1 | Dec 23, 2025 | |
| IKT Inhibikase Therapeutics | Initiated Coverage: Buy | $5 | $1.75 | +185.71% | 1 | Dec 1, 2025 | |
| TECX Tectonic Therapeutic | Maintained: Buy | $88 | $31.17 | +182.37% | 5 | Nov 18, 2025 | |
| RCKT Rocket Pharmaceuticals | Maintained: Buy | $9 | $3.07 | +193.16% | 17 | Nov 7, 2025 | |
| LRMR Larimar Therapeutics | Maintained: Buy | $22 | $3.48 | +532.18% | 21 | Nov 5, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintained: Buy | $85 → $84 | $59.40 | +41.41% | 14 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $67 | $61.86 | +8.31% | 22 | Nov 3, 2025 |
Tenaya Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $3 → $4
Current: $0.869
Upside: +360.30%
Prime Medicine
May 9, 2026
Rated: Buy
Price Target: $6
Current: $3.55
Upside: +69.01%
Mereo BioPharma Group
Jan 12, 2026
Maintained: Hold
Price Target: n/a
Current: $0.344
Upside: -
Crinetics Pharmaceuticals
Jan 5, 2026
Maintained: Buy
Price Target: $93 → $99
Current: $35.55
Upside: +178.48%
Sionna Therapeutics
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $60
Current: $42.82
Upside: +40.12%
Inhibikase Therapeutics
Dec 1, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.75
Upside: +185.71%
Tectonic Therapeutic
Nov 18, 2025
Maintained: Buy
Price Target: $88
Current: $31.17
Upside: +182.37%
Rocket Pharmaceuticals
Nov 7, 2025
Maintained: Buy
Price Target: $9
Current: $3.07
Upside: +193.16%
Larimar Therapeutics
Nov 5, 2025
Maintained: Buy
Price Target: $22
Current: $3.48
Upside: +532.18%
Tarsus Pharmaceuticals
Nov 5, 2025
Maintained: Buy
Price Target: $85 → $84
Current: $59.40
Upside: +41.41%
Nov 3, 2025
Maintained: Buy
Price Target: $54 → $67
Current: $61.86
Upside: +8.31%